Accenture plc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Accenture plc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	34,798	36,177	40,993	43,215	44,327	50,533	61,594	64,112	64,896	69,673
Cost of revenue	24,520	25,105	28,499	29,900	30,351	34,169	41,893	43,380	43,734	47,438
Gross profit	10,277	11,071	12,493	13,315	13,976	16,364	19,702	20,732	21,162	22,235
Research and development	643	704	791	800	871	1,118	1,123	1,299	1,150	817
Selling and marketing	3,580	3,752	4,196	4,447	4,626	5,288	6,108	6,583	6,847	7,043
General and administrative	1,887	2,128	2,398	2,562	2,837	3,454	4,226	4,276	4,281	4,351
Operating income	4,810	5,191	5,899	6,305	6,514	7,622	9,367	8,810	9,596	10,226
Interest expense	16.3	15.5	19.5	23	33.1	59.5	47.3	47.5	59	229
Interest income	30.5	37.9	56.3	87.5	69.3	33.4	45.1	280	272	336
Other non-operating income	-69.9	-87.7	-127	-118	224	166	-72.5	96.6	-110	-63
Pre-tax income	5,604	4,616	5,808	6,252	6,774	7,761	9,196	9,139	9,699	10,270
Income tax	1,254	981	1,593	1,406	1,589	1,771	2,207	2,136	2,280	2,438
Net income	4,112	3,445	4,060	4,779	5,108	5,907	6,877	6,872	7,265	7,678
EBITDA	5,539	5,993	6,826	7,198	7,536	8,749	10,686	10,222	11,039	10,848
EPS, basic	6.58	5.56	6.46	7.49	8.03	9.31	10.87	10.90	11.57	12.29
EPS, diluted	6.45	5.44	6.34	7.36	7.89	9.16	10.71	10.77	11.44	12.15
Shares, basic (weighted)	625	620	628	638	636	635	633	631	628	625
Shares, diluted (weighted)	668	660	655	650	648	646	643	639	636	632
Dividend per share	2.20	2.42	2.66	2.92	3.20	3.52	3.88	4.48	5.16	5.92

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	4,906	4,127	5,061	6,127	8,415	8,168	7,890	9,045	5,004	11,479
Short-term investments	2.88	3.01	3.19	3.31	94.3	4.29	3.97	4.58	5.4	5.95
Receivables	4,072	4,569	4,996	7,467	7,192	8,797	10,484	10,691	11,873	13,065
Other current assets	845	1,082	1,025	1,225	1,393	1,766	1,940	2,105	2,183	2,431
Total current assets	11,976	12,097	13,586	15,451	17,750	19,667	21,611	23,382	20,858	28,901
Property, plant and equipment	957	1,141	1,264	1,391	1,546	1,639	1,659	1,530	1,521	1,566
Lease right-of-use assets				0	3,183	3,183	3,019	2,637	2,757	2,740
Goodwill	3,609	5,002	5,383	6,206	7,710	11,126	13,133	15,573	21,120	22,536
Intangible assets	510	710	687	841	1,029	1,711	1,931	2,073	2,904	2,411
Long-term investments	199	212	216	240	325	330	318	197	335	721
Other non-current assets	989	1,226	1,186	1,400	1,646	2,455	2,668	739	1,307	1,522
Total assets	20,609	22,690	24,449	29,790	37,079	43,176	47,263	51,245	55,932	65,395
Accounts payable	1,281	1,525	1,349	1,647	1,350	2,274	2,559	2,491	2,744	2,696
Accrued liabilities	4,041	4,060	4,569	4,891	5,084	6,748	7,612	7,506	7,051	8,084
Deferred revenue	2,365	2,670	2,838	3,189	3,637	4,229	4,478	4,907	5,175	6,073
Short-term debt	2.77	2.91	5.34	6.41	7.82	12.1	9.18	105	946	114
Total current liabilities	8,879	9,824	10,152	11,062	12,663	15,709	17,523	18,009	18,976	20,352
Long-term debt	24.5	22.2	19.7	16.2	54.1	53.5	45.9	43.1	78.6	5,034
Lease liabilities				0	2,668	2,697	2,563	2,311	2,369	2,305
Other non-current liabilities	305	349	442	527	534	554	462	465	939	1,198
Total liabilities	12,420	12,980	13,724	14,962	19,579	23,079	24,516	24,787	26,764	33,154
Total debt	24.5	22.2	19.7	16.2	54.1	53.5	45.9	43.1	78.6	5,034
Paid-in capital	2,925	3,516	4,871	5,804	7,167	8,618	10,679	12,779	14,711	16,603
Retained earnings	7,880	7,082	7,952	10,422	12,376	13,989	18,204	19,316	23,082	21,019
Treasury stock	-2,592	-1,649	-2,117	-1,388	-2,566	-3,408	-6,678	-7,063	-10,565	-7,752
Other comprehensive income	-1,662	-1,095	-1,576	-1,841	-1,562	-1,419	-2,190	-1,743	-1,555	-1,465
Shareholders' equity	7,555	8,949	10,365	14,409	17,001	19,529	22,106	25,693	28,289	31,195
Minority interests	634	761	360	419	499	568	641	766	880	1,046
Total equity	8,189	9,710	10,725	14,828	17,499	20,097	22,747	26,459	29,168	32,241
Total liabilities and equity	20,609	22,690	24,449	29,790	37,079	43,176	47,263	51,245	55,932	65,395

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	4,112	3,445	4,060	4,779	5,108	5,907	6,877	6,872	7,265	7,678
Depreciation and amortization	729	802	927	893	1,022	1,128	1,319	1,412	1,443	622
Stock-based compensation	758	795	977	1,093	1,198	1,343	1,680	1,913	1,942	2,094
Deferred income tax	65.9	-364	94	-96.4	171	60.9	-213	-269	-94	357
Change in receivables	-177	-73.3	-711	-526	722	-1,472	-2,412	87.7	-602	-1,021
Change in payables	72.6	174	-168	177	-360	825	374	-171	46.5	-111
Cash from operations	4,667	4,973	6,027	6,627	8,215	8,975	9,541	9,524	9,131	11,474
Capital expenditures	-497	-516	-619	-599	-599	-580	-718	-528	-517	-600
Acquisitions	-933	-1,704	-658	-1,193	-1,532
Cash from investing	-610	-2,234	-1,250	-1,756	-1,895	-4,310	-4,261	-2,622	-7,062	-2,020
Debt issued							0	100	1,599	5,061
Debt repaid							0	0	-771	-932
Share buybacks	-2,605	-2,649	-2,639	-2,691	-2,916	-3,703	-4,116	-4,330	-4,525	-4,619
Dividends paid	-1,438	-1,568	-1,709	-1,864	-2,038	-2,236	-2,457	-2,827	-3,241	-3,700
Cash from financing	-3,489	-3,560	-3,709	-3,767	-4,049	-4,926	-5,311	-5,645	-6,064	-2,948
Exchange rate effect	-23	42.3	-134	-38.7	16.9	13.8	-248	-101	-46.3	-32.2
Net change in cash	545	-779	935	1,065	2,288	-247	-278	1,155	-4,041	6,474
Free cash flow	4,171	4,457	5,408	6,028	7,616	8,395	8,823	8,996	8,615	10,874
Interest paid	16.3	15.8	19.7	22.6	28.5	36.1	46	46.5	37.2	155
Income taxes paid	1,425	1,289	1,373	1,587	1,360	1,567	1,779	2,316	2,387	2,472

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $176.11 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.0%	Gross profit / revenue.
Operating margin	14.5%	Operating income / revenue.
EBITDA margin	15.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.6%	Pre-tax income / revenue.
Net margin	10.7%	Net income / revenue.
FCF margin	17.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	18.0%	Cash from operations / revenue.
Effective tax rate	25.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	24.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.3%	Net income / average total assets.
Return on invested capital (ROIC)	29.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	2.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.8%	Capital expenditures / revenue.
D&A / revenue	0.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	7.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	4.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	6.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	3.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	9.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-1.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	0.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	7.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	5.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	3.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	8.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	6.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	4.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	9.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	25.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	6.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	6.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	26.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	7.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	7.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	14.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	15.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	13.1%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	10.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	12.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	16.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	11.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	12.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.34x	Current assets / current liabilities.
Quick ratio	1.12x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.47x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.16x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	7.3%	Total debt / total assets.
Liabilities / assets	52.0%	Total liabilities / total assets.
Net debt	-$5.14B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.46x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	39.8x	Operating income / interest expense.
Working capital	$7.33B	Current assets - current liabilities.
Goodwill and intangibles / assets	40.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$4.07B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.06x	Revenue / average total assets.
Fixed asset turnover	45.1x	Revenue / average property, plant and equipment.
Receivables turnover	5.22x	Revenue / average receivables.
Days sales outstanding	70 days	365 x average receivables / revenue.
Days payables	23 days	365 x average accounts payable / cost of revenue.
FCF conversion	161.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	4.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$12.52	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$118.75	Revenue / diluted weighted shares.
FCF per share	$20.44	Free cash flow / diluted weighted shares.
Operating cash flow per share	$21.41	Cash from operations / diluted weighted shares.
Book value per share	$51.80	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.61	Tangible book value / shares outstanding.
Cash per share	$16.52	(Cash + short-term investments) / shares outstanding.
Payout ratio	50.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	31.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	45.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$117.56B	Share price x shares outstanding.
Enterprise value	$112.41B	Market cap + total debt - cash - short-term investments.
P/E	15.1x	Market cap / net income. Only when net income is positive.
P/S	1.61x	Market cap / revenue.
P/B	3.69x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	28.9x	Market cap / tangible book value, when positive.
P/FCF	9.34x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.92x	Market cap / cash from operations, when positive.
EV/Sales	1.54x	Enterprise value / revenue.
EV/EBIT	10.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	10.0x	Enterprise value / EBITDA, when both are positive.
EV/FCF	8.93x	Enterprise value / free cash flow, when both are positive.
FCF yield	10.7%	Free cash flow / market cap.
Earnings yield	6.6%	Net income / market cap (the inverse of P/E).
Dividend yield	3.3%	Dividends paid over the period / market cap.
Shareholder yield	8.2%	(Dividends paid + share buybacks) / market cap.
PEG	3.51x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Accenture plc's revenue in fiscal 2025?

Accenture plc reported revenue of $69.67B for fiscal 2025, 7.4% higher than the year before.

Was Accenture plc profitable in fiscal 2025?

Yes. Net income was $7.68B, a net margin of 11%.

How much free cash flow did Accenture plc generate in fiscal 2025?

Cash from operations of $11.47B minus capital expenditures of $600.0M left free cash flow of $10.87B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Accenture plc